Proper nucleic acid extraction is crucial to any downstream molecular-based detection of the SARS-CoV-2 or other RNA viruses. MGI offers efficient and reliable RNA extraction solution from SARS-CoV-2 samples with the MGIEasy Nucleic Acid Extraction Kits and the high throughput, MGISP-960 automated sample preparation system. This workflow solution for viral RNA extraction is compatible with samples collected from throat (oropharyngeal) swabs, nasopharyngeal swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal washes, nasal aspirates and bronchoalveolar lavage fluid (BALF).
The workflow can be further automated using the MGISTP-7000 robotic capper/decapper, capable of scanning and preparing 192 samples from transport tubes in less than 40 minutes.
For Emergency Use Authorization Only | For in vitro diagnostic use | Rx Only
MGI’s viral RNA extraction kit addresses the severe bottleneck in viral sample preparation and is in abundant supply. Optimized chemistry is specifically designed for highly efficient DNA and RNA isolation from various sample types using superparamagnetic bead technology– all in just 1 hour. Extracted nucleic acid is suitable for any downstream molecular detection including PCR, RT-PCR, and next-generation sequencing. All MGIEasy Nucleic Acid Extraction Kits are manufactured in ISO 13485 compliant facilities.
The MGISP-960RS is a high-throughput automated extraction and liquid handling workstation, which can be used with MGIEasy Nucleic Acid Extraction Kits to perform 96 viral nucleic acid extractions within one hour. Additionally, it can prepare the RT-PCR mixture following extraction.
A versatile automated sample transfer system capable of processing up to 6,000 samples per day, the MGISTP-7000 integrates tube decapping, recapping, barcode identification, and automated liquid transfer. This system can also pool VTM samples and provide accessioning, while significantly reducing the number of technicians required to scale-up a laboratory.